Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin.

作者
K Katoch,U Ramanathan,Mohan Natrajan,Bagga Ak,Bhatia As,Saxena Rk,Golkonda Ramu
出处
期刊:PubMed [National Institutes of Health]
卷期号:57 (2): 458-64 被引量:10
链接
标识
摘要

Three multidrug regimens all containing rifampin and dapsone have been tried for the treatment of 278 cases of paucibacillary leprosy. Regimen I was the one recommended by the WHO Study Group. Regimen II was the same as Regimen I with depsone alone continued for a further 6 months. Regimen III was the same as Regimen II but rifampin was given daily for the first 7 days. The patients were comparable with regard to disease classification, lepromin status, bacteriological status, and number of lesions. As reported earlier, the disease inactivity rates by 1 year of treatment were much greater with Regimens II and III than with Regimen I (94% and 97% vs 76%). Early reaction was seen in 6% of those in Regimen III and in none in Regimens I and II. Late reaction was observed in 9% of those in Regimen I and none in Regimens II and III. During 3 1/2 years of follow up, 13% of the cases in Regimen I, 1% in Regimen II, and 2% in Regimen III relapsed. Since the patients in the three regimens were otherwise comparable, it is concluded that the high inactivity rate, low relapse rate (1%-2%), and no early or late reaction as observed in Regimen II patients were because of adequate treatment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
标致青雪发布了新的文献求助10
刚刚
1秒前
ebao完成签到 ,获得积分10
1秒前
Rainbow发布了新的文献求助10
1秒前
JL发布了新的文献求助10
1秒前
ACC完成签到,获得积分10
1秒前
2秒前
余香的应助被sunny采纳,获得10
2秒前
余香的应助被sunny采纳,获得10
2秒前
香蕉觅云的应助被逍遥子采纳,获得10
2秒前
3秒前
超级小飞侠完成签到 ,获得积分10
3秒前
04d的应助被秋木澪采纳,获得10
4秒前
4秒前
4秒前
田様的应助被jianrun采纳,获得10
5秒前
咩咩橙子完成签到,获得积分10
5秒前
5秒前
小小完成签到 ,获得积分10
5秒前
niu关注了科研通微信公众号
5秒前
之之发布了新的文献求助10
5秒前
薪尘发布了新的文献求助10
6秒前
6秒前
04d的应助被xuetian采纳,获得10
6秒前
Demon发布了新的文献求助10
6秒前
超级小熊猫完成签到,获得积分10
7秒前
刘六柳发布了新的文献求助10
7秒前
8秒前
yl发布了新的文献求助10
8秒前
李爱国的应助被ny960采纳,获得10
8秒前
小七发布了新的文献求助10
8秒前
8秒前
刘轩瑀发布了新的文献求助100
8秒前
Pengpeng发布了新的文献求助200
9秒前
18621058639完成签到,获得积分10
9秒前
10秒前
heinnie发布了新的文献求助10
10秒前
科研通AI6.3的应助被张朗星采纳,获得20
10秒前
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182352
求助须知:如何正确求助?哪些是违规求助? 9571930
关于积分的说明 21820825
捐赠科研通 7778861
什么是DOI,文献DOI怎么找? 3433657
关于科研通互助平台的介绍 2557824
邀请新用户注册赠送积分活动 2479703